MAPK8 and glioblastoma: Matsuda et al. [95] found that JNK inactivation via siRNA or SP600125 reduced stemness in glioblastoma cells, as measured by spheroid formation and marker expression (nestin, SOX2, Musashi-1), and induced differentiation.